Why US patent reform is ‘essential’ for US economic prosperity and security

Proposed patent legislation will save US innovation and counter the ‘existential threat’ that China poses to the West, hears Sarah Speight.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Strategic IP protection for biotech-related GenAI

24 April 2025 Generative AI is transforming the biotech industry, so it’s crucial to have an IP strategy—in particular, for trade secret and/or patent protection. Dean Pelletier of Pelletier Law explains.

Americas

How pharma should prep for the six-bill avalanche from Congress

17 April 2025 The bipartisan legislative push could create big hurdles for drug development, with concerns mounting over limited patent protections and increased litigation risks, hears Marisa Woutersen.

Europe

EPO: Biotech innovation strong, while pharma trails behind

8 April 2025 According to the Patent Index 2024, patent filings remained high in Europe last year “despite political and economic uncertainties” | Johnson & Johnson ranked among the top requesters of unitary patents.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Why US patent reform is ‘essential’ for US economic prosperity and security

More on this story

Editor's picks

Editor's picks

More features